ATRA vs REGN: Which Stock is Better?

Side-by-side comparison of Atara Biotherapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ATRA

Atara Biotherapeutics Inc

$4.32

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricATRAREGNWinner
Market Cap$32.73M$77.69BREGN
P/E Ratio1.5917.57ATRA
EPS (TTM)$2.86$41.71REGN
Revenue Growth-0.9%0.0%REGN
Gross Margin46.8%45.8%ATRA

Analyze ATRA

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ATRA or REGN a better investment?

Comparing ATRA and REGN: Atara Biotherapeutics Inc has a market cap of $32.73M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ATRA and REGN?

ATRA (Atara Biotherapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ATRA or REGN?

Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 17.6x).

Which is growing faster: ATRA or REGN?

REGN has higher revenue growth at 0.0% vs -0.9% for ATRA.

Which company is more profitable: ATRA or REGN?

Atara Biotherapeutics Inc (ATRA) has higher gross margins at 46.8% compared to 45.8% for REGN.

Which is the larger company: ATRA or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $32.73M for ATRA.

Should I buy ATRA or REGN in 2026?

Both ATRA and REGN have investment merit. ATRA trades at $4.32 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ATRA and REGN stock?

Key differences: Market Cap ($32.73M vs $77.69B), P/E Ratio (1.6x vs 17.6x), Revenue Growth (-0.9% vs 0.0%), Gross Margin (46.8% vs 45.8%).

Popular Stock Comparisons